Corneal collagen crosslinking has revolutionized the treatment of keratoconus and post-
refractive corneal ectasia in the past decade. Corneal crosslinking with riboflavin and …

Since the late 1990s corneal crosslinking (CXL) has been proposed as a new possibility to
stop progression of keratoconus or secondary corneal ectasia, with the promising aim to …

PURPOSE: To compare the long-term changes in corneal biomechanics, topography, and
tomography before and 4 years after corneal cross-linking (CXL) with the Dresden protocol …

Purpose To evaluate the effectiveness of epithelium-off (epi-off) accelerated corneal
crosslinking (A-CXL, 9 mW/cm2, 10 min) in adult keratoconus (KC) patients. Methods The …

Purpose To compare the efficacy of epithelium-off corneal collagen crosslinking (CXL) with
transepithelial CXL in patients with progressive keratoconus with a follow-up of 3 years …

Keratoconus is an ectatic disorder that is presently considered one of the most prevalent
reasons for keratoplasty. Corneal collagen crosslinking (CXL) is the only proven treatment …

Purpose Long-term evaluation of functional results based on visual acuity, keratometry,
spherical equivalent and refractive cylinder in patients with progressive keratoconus treated …

Purpose: The present study aimed to report the outcomes of patients with progressive
keratoconus who were treated via accelerated crosslinking (CXL) 6 months earlier and to …

PURPOSE: To evaluate the clinical results of epitheliumoff corneal cross-linking (CXL)
during a 7-year follow-up. METHODS: This retrospective, non-randomized, single-center …

PURPOSE: The purpose of the study is to evaluate the safety and outcomes of corneal
collagen cross-linking (CXL) and different CXL protocols in progressive keratoconus (PK) …